Drag a card by its title · ⚙ to size, swap or remove

The company

Aura Biosciences, Inc.

AURA · Nasdaq

Health CareBiotechnologyNot moving yet

AURA stood above a rising 150-day average in 26 of the last 52 weekly readings, and has been out of that trend for the last 5 weeks. It is 10.5% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 5
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $79.8M
Officials’ trades on record: 0
Institutions holding: 145 (+22)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 26 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months13

Buyers · sellers0 · 7

Who	Did	Shares	Traded
Anthony S. GibneyOfficer	sold	12,824at $6.42	16 Jun 2026filed 16 Jun 2026
Matrix Capital Management Company, Lp10% owner	sold	6,922,870at $5.64	7 May 2026filed 11 May 2026
Conor KilroyOfficer	sold	11,738at $7.02	16 Apr 2026filed 16 Apr 2026
Los Pinos Elisabet DeDirector, Officer	sold	47,648at $5.06	17 Feb 2026filed 17 Feb 2026
Amy ElazzouziSenior Vice President, Finance	sold	8,549at $5.06	17 Feb 2026filed 17 Feb 2026
Janet Jill HopkinsChief Medical Officer	sold	20,401at $5.06	17 Feb 2026filed 17 Feb 2026
Mark PlavsicChief Technology Officer	sold	15,890at $5.05	17 Feb 2026filed 17 Feb 2026
Conor KilroyOfficer	sold	12,079at $5.05	17 Feb 2026filed 17 Feb 2026
Los Pinos Elisabet DeDirector, Officer	sold	16,928at $4.86	20 Jan 2026filed 20 Jan 2026
Amy ElazzouziSenior Vice President, Finance	sold	1,581at $4.86	20 Jan 2026filed 20 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders145+22 on the quarter

New · exited39 · 16

Reported value$676.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
TCG Crossover Management, LLCnew · filed 14 Aug 2026	9,533,333$67.7M	+9,533,333
MONTANOVA CAPITAL, LLCadded · filed 14 Aug 2026	7,206,217$51.2M	+2,833,333+64.8%
Frazier Life Sciences Management, L.P.added · filed 14 Aug 2026	7,100,000$50.4M	+2,000,000+39.2%
Long Focus Capital Management, LLCadded · filed 14 Aug 2026	5,119,582$36.3M	+500,000+10.8%
BlackRock, Inc.added · filed 7 Aug 2026	4,707,674$33.4M	+1,121,034+31.3%
ADAGE CAPITAL PARTNERS GP, L.L.C.reduced · filed 14 Aug 2026	4,640,000$32.9M	-241,125−4.9%
Caligan Partners LPadded · filed 14 Aug 2026	4,298,248$30.5M	+4,068,384+1769.9%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	4,100,342$29.1M	+1,856,514+82.7%
FCPM III SERVICES B.V.new · filed 14 Aug 2026	4,053,775$28.8M	+4,053,775
ORBIMED ADVISORS LLCnew · filed 14 Aug 2026	3,333,333$23.7M	+3,333,333